Since anti-leukemic activity of chemotherapeutic agents are dependent on cell cycle progression, we analyzed the association of the susceptibility-linked and relapsed-linked SNPs of ARID5B with cell cycle progression in BCP-ALL cell lines. Here, ARID5B is linked to acute lymphoblastic leukemia.